← Evidence map

ReviewImmuno-oncology technology2023

Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond.

C Gerard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37483658